drugset / Trial / NCT02515864

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

NCT02515864

Phase 2 Completed 48 enrolled Fuji Yakuhin Co., Ltd.
RandomizedCrossoverQuadruple-blindBasic science

Summary

A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on QT/QTc Interval of a Single Dose of FYU-981, Compared with Placebo, Using Moxifloxacin as a Positive Control, in Healthy Male and Female Volunteers.

Timeline

Start
2015-08
Primary completion
2016-03
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dotinurad Small molecule Oral
Comparator Moxifloxacin Small molecule Oral

Indications

No indication recorded.